Search for: "New Pharma, Inc." Results 41 - 60 of 991
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Aug 2022, 11:39 am by Eileen McDermott
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
18 Aug 2022, 11:39 am by Eileen McDermott
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
12 Aug 2022, 6:48 pm by Lawrence B. Ebert
Epic Pharma, LLC, 811 F.3d 1345, 1353–54 (Fed. [read post]
With AmerisourceBergen Drug Corporation, Purdue Pharma L.P., and Endo Pharmaceuticals Inc being sued previously. [read post]
Despite the fact that public health care plays a relevant role, courts showing a commitment to balance IP rights and allow pharmaceutical companies to continue invest in new drugs to treat complex diseases. [read post]
27 Jul 2022, 11:00 am by Zak Gowen
Here are some of the developments in antitrust news this past week that we found interesting and are following. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
Jan. 10, 2013) (dismissing where defendant characterized clinical trial results positively even though FDA had expressed concerns and contemporaneous news reports described the results as disappointing). [read post]
13 Jun 2022, 1:11 pm by jeffreynewmanadmin
In a complaint filed May 20, the United States alleged that Edge Pharm Inc., and its owners and operators Marc Chatoff and Kurt Radke, violated the FDCA by manufacturing and distributing adulterated and misbranded drugs, by causing drugs to becoming adulterated and misbranded while held for sale, and by introducing new unapproved drugs into interstate commerce. [read post]
1 Jun 2022, 12:35 pm by Tom Lamb
This recent FDA action formalizes an April 15, 2022 announcement by TG Therapeutics Inc. that it is pulling Ukoniq from the market after a study showed a possible increased risk of death in patients taking the drug. [read post]
25 May 2022, 1:57 pm by Kevin LaCroix
  Background Cocrystal Pharma, Inc. was formed in April 2014 through a reverse merger that took place between Biozone Pharmaceuticals and Cocrystal Discovery. [read post]
25 May 2022, 2:26 am by Matrix Legal Support Service
On appeal from [2020] EWCA Civ 617 The Respondent is a public body tasked with investigating companies suspected of breaching competition law and penalising those found to have done so. [read post]
13 Mar 2022, 9:41 am by Dave Maass
Back in 2015, Wu-Tang Clan produced Once Upon a Time in Shaolin, but they only produced one copy and sold it to the highest bidder: pharma-bro Martin Shkreli, who was later convicted of securities fraud. [read post]